The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Responses of Pseudomonas aeruginosa to antimicrobials
Open accessAbstract
Infections caused by Pseudomonas aeruginosa often are hard to treat; inappropriate chemotherapy readily selects multidrug-resistant P. aeruginosa. This organism can be exposed to a wide range of concentrations of antimicrobials during treatment; learning more about the responses of P. aeruginosa to antimicrobials is therefore important. We review here responses of the bacterium P. aeruginosa upon exposure to antimicrobials at levels below the inhibitory concentration. Carbapenems (e.g., imipenem) have been shown to induce the formation of thicker and more robust biofilms, while fluoroquinolones (e.g., ciprofloxacin) and aminoglycosides (e.g., tobramycin) have been shown to induce biofilm formation. Ciprofloxacin also has been demonstrated to enhance the frequency of mutation to carbapenem resistance. Conversely, although macrolides (e.g., azithromycin) typically are not effective against P. aeruginosa because of the pseudomonal outer-membrane impermeability and efflux, macrolides do lead to a reduction in virulence factor production. Similarly, tetracycline is not very effective against this organism, but is known to induce the type-III secretion system and consequently enhance cytotoxicity of P. aeruginosa in vivo. Of special note are the effects of antibacterials and disinfectants on pseudomonal efflux systems. Sub-inhibitory concentrations of protein synthesis inhibitors (aminoglycosides, tetracycline, chloramphenicol, etc.) induce the MexXY multidrug efflux system. This response is known to be mediated by interference with the translation of the leader peptide PA5471.1, with consequent effects on expression of the PA5471 gene product. Additionally, induction of the MexCD-OprJ multidrug efflux system is observed upon exposure to sub-inhibitory concentrations of disinfectants such as chlorhexidine and benzalkonium. This response is known to be dependent upon the AlgU stress response factor. Altogether, these biological responses of P. aeruginosa provide useful clues for the improvement and optimization of chemotherapy in order to appropriately treat pseudomonal infections while minimizing the emergence of resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
beta-Lactamases in laboratory and clinical resistance
Livermore, D. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.557 · Cited by 1,779
Aminoglycoside antibiotics induce bacterial biofilm formation
Hoffman, L. R., D'Argenio, D. A., MacCoss, M. J., Zhang, Z., Jones, R. A., & Miller, S. I. (2005) · Nature · doi:10.1038/nature03912 · Cited by 1,321
The type III secretion system of Pseudomonas aeruginosa: infection by injection
Hauser, A. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2199 · Cited by 968
Pseudomonas Aeruginosa: Resistance to the Max
Poole, K. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00065 · Cited by 948
Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation
Overhage, J., Campisano, A., Bains, M., Torfs, E. C. W., Rehm, B. H. A., & Hancock, R. E. W. (2008) · Infection and Immunity · doi:10.1128/iai.00318-08 · Cited by 696
Antibiotics as intermicrobial signaling agents instead of weapons
Linares, J. F., Gustafsson, I., Baquero, F., & Martinez, J. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608949103 · Cited by 658
Mechanism of bactericidal action of aminoglycosides
Davis, B. D. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.3.341-350.1987 · Cited by 620
Improvement of Survival in Patients with Diffuse Panbronchiolitis Treated with Low-dose Erythromycin
KUDOH, S., AZUMA, A., YAMAMOTO, M., IZUMI, T., & ANDO, M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9710075 · Cited by 582
Cathelicidins: family of antimicrobial peptides. A review
Kościuczuk, E. M., Lisowski, P., Jarczak, J., Strzałkowska, N., Jóźwik, A., Horbańczuk, J., Krzyżewski, J., Zwierzchowski, L., & Bagnicka, E. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1997-x · Cited by 570
Mechanisms of bacterial biocide and antibiotic resistance: ANTIBIOTIC AND BIOCIDE RESISTANCE
Poole, K. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.8.x · Cited by 513
Antimicrobial Agents and Chemotherapy
(2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac · Cited by 485
Aminoglycoside Resistance in Pseudomonas aeruginosa
Poole, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.479-487.2005 · Cited by 470
McPhee, J. B., Lewenza, S., & Hancock, R. E. W. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03673.x · Cited by 443
Azithromycin Inhibits Quorum Sensing in Pseudomonas aeruginosa
Tateda, K., Comte, R., Péchère, J.-C., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1930-1933.2001 · Cited by 401
Morita, Y., Kodama, K., Shiota, S., Mine, T., Kataoka, A., Mizushima, T., & Tsuchiya, T. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1778 · Cited by 391
Self-citationEffects of Antibiotics on Quorum Sensing in Pseudomonas aeruginosa
Skindersoe, M. E., Alhede, M., Phipps, R., Yang, L., Jensen, P. O., Rasmussen, T. B., Bjarnsholt, T., Tolker-Nielsen, T., Høiby, N., & Givskov, M. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01230-07 · Cited by 364
Resistance to ?-lactam antibiotics
Poole, K. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4060-9 · Cited by 358
Zhang, L., Dhillon, P., Yan, H., Farmer, S., & Hancock, R. E. W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3317-3321.2000 · Cited by 349
Bagge, N., Schuster, M., Hentzer, M., Ciofu, O., Givskov, M., Greenberg, E. P., & Høiby, N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1175-1187.2004 · Cited by 345
Fernández, L., Gooderham, W. J., Bains, M., McPhee, J. B., Wiegand, I., & Hancock, R. E. W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00242-10 · Cited by 320
Nalca, Y., Jänsch, L., Bredenbruch, F., Geffers, R., Buer, J., & Häussler, S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1680-1688.2006 · Cited by 317
β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein
Moya, B., Dötsch, A., Juan, C., Blázquez, J., Zamorano, L., Haussler, S., & Oliver, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000353 · Cited by 287
Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1
Dean, C. R., Visalli, M. A., Projan, S. J., Sum, P.-E., & Bradford, P. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.972-978.2003 · Cited by 286 · cited 2×
“P. aeruginosa is intrinsically resistant to tetracyclines and glycylcyclines due to the MexAB/MexXY efflux systems (Morita et al., 2001; Dean et al., 2003).”
BackgroundLong-term azithromycin may improve lung function in children with cystic fibrosis
Jaffé, A., Francis, J., Rosenthal, M., & Bush, A. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78360-4 · Cited by 276
Cirz, R. T., O'Neill, B. M., Hammond, J. A., Head, S. R., & Romesberg, F. E. (2006) · Journal of Bacteriology · doi:10.1128/jb.00807-06 · Cited by 276
Moskowitz, S. M., Brannon, M. K., Dasgupta, N., Pier, M., Sgambati, N., Miller, A. K., Selgrade, S. E., Miller, S. I., Denton, M., Conway, S. P., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05829-11 · Cited by 230
Miller, A. K., Brannon, M. K., Stevens, L., Johansen, H. K., Selgrade, S. E., Miller, S. I., Høiby, N., & Moskowitz, S. M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05391-11 · Cited by 224
Zhu, L., Lin, J., Ma, J., Cronan, J. E., & Wang, H. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01152-09 · Cited by 201
MexXY multidrug efflux system of Pseudomonas aeruginosa
Morita, Y., Tomida, J., & Kawamura, Y. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00408 · Cited by 196
Self-citationMc Cay, P. H., Ocampo-Sosa, A. A., & Fleming, G. T. A. (2010) · Microbiology · doi:10.1099/mic.0.029751-0 · Cited by 180
Yan, A., Guan, Z., & Raetz, C. R. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706172200 · Cited by 169
Fraud, S., Campigotto, A. J., Chen, Z., & Poole, K. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01072-08 · Cited by 166
Morita, Y., Murata, T., Mima, T., Shiota, S., Kuroda, T., Mizushima, T., Gotoh, N., Nishino, T., & Tsuchiya, T. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg173 · Cited by 161
Self-citationCiprofloxacin Induction of a Susceptibility Determinant in Pseudomonas aeruginosa
Brazas, M. D., & Hancock, R. E. W. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3222-3227.2005 · Cited by 160
Morita, Y., Sobel, M. L., & Poole, K. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.5.1847-1855.2006 · Cited by 158
Self-citationCharacterization of the Polymyxin B Resistome of Pseudomonas aeruginosa
Fernández, L., Alvarez‐Ortega, C., Wiegand, I., Olivares‐Pacheco, J., Kocíncová, D., Lam, J. S., Martínez, J. L., & Hancock, R. E. W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01583-12 · Cited by 155
Mima, T., Joshi, S. M., Escalada, M. G., & Schweizer, H. P. (2007) · Journal of Bacteriology · doi:10.1128/jb.00850-07 · Cited by 153
A new member of the tripartite multidrug efflux pumps,MexVW-OprM, in Pseudomonas aeruginosa
Li, Y. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg390 · Cited by 151
He, G.-X., Kuroda, T., Mima, T., Morita, Y., Mizushima, T., & Tsuchiya, T. (2003) · Journal of Bacteriology · doi:10.1128/jb.186.1.262-265.2004 · Cited by 136
Self-citationFetar, H., Gilmour, C., Klinoski, R., Daigle, D. M., Dean, C. R., & Poole, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00830-10 · Cited by 134
Guénard, S., Muller, C., Monlezun, L., Benas, P., Broutin, I., Jeannot, K., & Plésiat, P. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01252-13 · Cited by 119
Marr, A. K., Overhage, J., Bains, M., & Hancock, R. E. W. (2007) · Microbiology · doi:10.1099/mic.0.2006/002519-0 · Cited by 116
Masuda, N., Gotoh, N., Ishii, C., Sakagawa, E., Ohya, S., & Nishino, T. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.400 · Cited by 114
Morita, Y., Kimura, N., Mima, T., Mizushima, T., & Tsuchiya, T. (2001) · The Journal of General and Applied Microbiology · doi:10.2323/jgam.47.27 · Cited by 111
Self-citationBuyck, J. M., Plésiat, P., Traore, H., Vanderbist, F., Tulkens, P. M., & Françoise Van Bambeke, A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis473 · Cited by 107
PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa
Blázquez, J., Gómez‐Gómez, J., Oliver, A., Juan, C., Kapur, V., & Martín, S. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05366.x · Cited by 105
Kindrachuk, K. N., Fernández, L., Bains, M., & Hancock, R. E. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00935-10 · Cited by 99
Mao, W., Warren, M. S., Lee, A. Y., Mistry, A., & Lomovskaya, O. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2001-2007.2001 · Cited by 82
Determinants of Intrinsic Aminoglycoside Resistance in Pseudomonas aeruginosa
Krahn, T., Gilmour, C., Tilak, J., Fraud, S., Kerr, N. P., Lau, C. H., & Poole, K. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01446-12 · Cited by 79
Tanimoto, K., Tomita, H., Fujimoto, S., Okuzumi, K., & Ike, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00464-08 · Cited by 78
Sekiya, H., Mima, T., Morita, Y., Kuroda, T., Mizushima, T., & Tsuchiya, T. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2990-2992.2003 · Cited by 77
Self-citationCummins, J., Reen, F. J., Baysse, C., et al. (2009) · Microbiology · doi:10.1099/mic.0.025643-0 · Cited by 73
Hay, T. J. M., Fraud, S., Lau, C. H., Gilmour, C., & Poole, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056858 · Cited by 71
Chiang, W., Pamp, S. J., Nilsson, M., et al. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00929.x · Cited by 71
Morita, Y., Tomida, J., & Kawamura, Y. (2012) · Microbiology · doi:10.1099/mic.0.054320-0 · Cited by 64
Self-citationMorita, Y., Gilmour, C., Metcalf, D. S., & Poole, K. (2009) · Journal of Bacteriology · doi:10.1128/jb.00073-09 · Cited by 62
Self-citationAntibiotic research in the age of omics: from expression profiles to interspecies communication
Wecke, T., & Mascher, T. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr373 · Cited by 62
Breidenstein, E. B. M., Bains, M., & Hancock, R. E. W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06014-11 · Cited by 61
Hächler, H., Santanam, P., & Kayser, F. H. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1254 · Cited by 59
Lutz, L., Pereira, D. C., Paiva, R. M., Zavascki, A. P., & Barth, A. L. (2012) · BMC Microbiology · doi:10.1186/1471-2180-12-196 · Cited by 50
Brazas, M. D., Breidenstein, E. B. M., Overhage, J., & Hancock, R. E. W. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00830-07 · Cited by 48
Köhler, T., Dumas, J.-L., & van Delden, C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00613-07 · Cited by 47
Aminov, R. I. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00241 · Cited by 45
Global Transcriptomic Response of Pseudomonas aeruginosa to Chlorhexidine Diacetate
Nde, C. W., Jang, H.-J., Toghrol, F., & Bentley, W. E. (2009) · Environmental Science & Technology · doi:10.1021/es9015475 · Cited by 40
Mutations in 23S rRNA Confer Resistance against Azithromycin in Pseudomonas aeruginosa
Marvig, R. L., Søndergaard, M. S. R., Damkiær, S., Høiby, N., Johansen, H. K., Molin, S., & Jelsbak, L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00630-12 · Cited by 33
Sugimura, M., Maseda, H., Hanaki, H., & Nakae, T. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00511-08 · Cited by 26
Pseudomonas aeruginosa: A Persistent Pathogen in Cystic Fibrosis and Hospital-Associated Infections
Schurek, K. N., Breidenstein, E. B. M., & Hancock, R. E. W. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1400-1_21 · Cited by 15
Cited by
Understanding the mechanisms and drivers of antimicrobial resistance
Holmes, A. H., Moore, L. S. P., Sundsfjord, A., Steinbakk, M., Regmi, S., Karkey, A., Guerin, P. J., & Piddock, L. J. V. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00473-0 · Cited by 2,611
Antibiotic resistance: a rundown of a global crisis
Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., Muzammil, S., Rasool, M. H., Nisar, M. A., Alvi, R. F., Aslam, M. A., Qamar, M. U., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s173867 · Cited by 2,552
Antibiotic Modulation of Capsular Exopolysaccharide and Virulence in Acinetobacter baumannii
Geisinger, E., & Isberg, R. R. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004691 · Cited by 548
Resistance Toward Chlorhexidine in Oral Bacteria – Is There Cause for Concern?
Cieplik, F., Jakubovics, N. S., Buchalla, W., Maisch, T., Hellwig, E., & Al-Ahmad, A. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00587 · Cited by 424
Quaternary ammonium disinfectants: microbial adaptation, degradation and ecology
Tezel, U., & Pavlostathis, S. G. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.03.018 · Cited by 393
Metadata
- Authors
- Morita, Y., Tomida, J., & Kawamura, Y.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2014
- Volume
- 4
- Pages
- 422-422
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2012472444
- Cited by
- 344
- References
- 67
- FWCI
- 13.26
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.